Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Phosphoric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN10554191918A reveals high-yield chiral catalyst synthesis. Offers supply chain stability and cost efficiency for asymmetric pharmaceutical manufacturing processes.
Patent CN117088828A details asymmetric catalysis for chiral fluorene. Enhances OLED material stability and offers cost reduction in electronic chemical manufacturing.
Discover the advanced synthesis of NOBIN-type axial chiral biaryl compounds via patent CN116535329B. Offers high enantioselectivity, metal-free catalysis, and scalable manufacturing for global pharmaceutical supply chains.
Novel patent CN116655694A enables metal-free synthesis. Delivers high purity catalysts for asymmetric reactions with reduced supply chain complexity and cost.
Patent CN108409746B details a novel chiral phosphoric acid catalyzed synthesis of spirooxindoles, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN112299962B reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate synthesis, offering significant cost reduction and supply chain reliability.
Novel biphenanthrene skeleton catalyst offers high enantioselectivity for spiroketal manufacturing, ensuring supply chain stability and cost efficiency.
Novel chiral phosphoric acid catalysis method offers high yield and mild conditions for scalable pharmaceutical intermediate manufacturing supply chain optimization and cost efficiency.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN113150031A discloses a novel oxaspiro chiral phosphoric acid enabling >97% ee in asymmetric synthesis. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN112299962A reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate production, offering significant cost reduction and equipment longevity.
Novel chiral phosphoric acid catalyzed method offers high yield and mild conditions for pharmaceutical intermediate manufacturing supply chain optimization and reliability.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Patent CN106631702A reveals high-yield chiral phosphoric acid catalysis for SPINOL. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel photocatalytic synthesis of chiral alpha,alpha-diaryl ketones overcomes racemization. Ideal for API intermediates. Cost-effective scale-up and reliable supply.
Patent CN102516145A reveals a novel Brønsted acid-catalyzed method for asymmetric selenofunctionalization, offering a metal-free route for high-purity pharmaceutical intermediates with simplified supply chains.
Patent CN109748883B details a metal-free asymmetric ring-opening method for high-purity chiral beta-amino derivatives, offering significant cost reduction and scalability for pharmaceutical intermediates manufacturing.
Patent CN100548979C details a metal-free, high-yield route to optically active 3-aminoindoles using chiral phosphoric acids, offering significant supply chain advantages.
Patent CN110452150A reveals a novel chiral phosphoric acid catalyzed synthesis. Offers mild conditions and high enantioselectivity for reliable supply chain integration.